Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials

Author(s):
Bottomley, A.; Pe, M.; Sloan, J.; Basch, E.; Bonnetain, F.; Calvert, M.; Campbell, A.; Cleeland, C.; Cocks, K.; Collette, L.; Dueck, A.C.; Devlin, N.; Flechtner, H.H.; Gotay, C.; Greimel, E.; Griebsch, I.; Groenvold, M.; Hamel, J.F.; King, M.; Kluetz, P.G.; Koller, M.; Malone, D.C.; Martinelli, F.; Mitchell, S.A.; Moinpour, C.M.; Musoro, J.Z.; O'Connor, D.; Oliver, K.; Piault-Louis, E.; Piccart, M.; Pimentel, F.L.; Quinten, C.; Reijneveld, J.C.; Schurmann, C.; Smith, A.W.; Soltys, K.M.; Sridhara, R.; Taphoorn, M.J.B.; Velikova, G.; Coens, C.; Setting Int Stand Analyzing
Published
2018
Publication type
Article / Letter to editor
Guidelinesstandardscancer clinical trialshealth-related quality of lifepatient-reported outcomes
Date issued
2018-12-31
Language
English
Is part of
Clinical Trials (2018), Vol. 15, no. 6, p. 624-630
hdl
1887/96512
doi
10.1177/1740774518795637